1. Field of The Invention
The invention relates to a method for stratifying patient risk and prioritizing care opportunities based on the potential or probability of avoidable costs.
2. Description of the Related Art
Health systems, payers and provider organizations, especially those involved in risk or quality-based reimbursement, do not have a solution identifies patients based on their potential avoidable costs. This leads to a number of problems such as; lacking a way to measure the effectiveness and return on investment of their care management programs and care managers, directing their resources to the patients with the highest potential for a positive financial or quality impact, determining what patients to focus on, and how many resources are needed. They have no way of truly knowing if the patients assigned to each care manager are doing better because of their actions or because the patient manages their own condition. They cannot determine the impact of their care management programs effectiveness. Current systems base acuity and stratify largely on claims data, diagnosis and comorbidities. These systems do not include sophisticated predictive algorithms that score a patient by quantifying the potential for avoidable costs and improved outcomes based on detailed discrete information including but not limited to medical, social, family histories, economic information, credit scores or knowledge that the patient personally tracks their biometrics such as pulse, oxygen levels and blood sugar.
A method maximizes the usefulness of resources to be allocated to a class of patients. The method includes the steps of receiving data on a patient. The date is then partitioned. From the partitioned data, a patient factor score calculation is calculated. In addition, a patient illness correlation score is calculated. From the patient factor score and patient illness correlation score, an Ability to Impact score for each patient is generated to identify uses of resources by which the resources will be applied to the patient to maximize the effectiveness of the resources.
Advantages of the invention will be readily appreciated, as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
The invention identifies, scores and ranks patients and populations based on the potential for avoidable costs. More specifically, the invention identifies and highlights patients based on predictive factors that indicate when an intervention will lead to avoidable costs. By way of example, there is a low probability of reducing significant costs or improving outcome significantly by assigning a care manager and/or social worker to a patient with fourth stage cancer.
In another example, two patients with chronic obstructive pulmonary disease (COPD) are compared. By looking at combinations of factors like depression, cohabitation, medications, medication compliance, socialization, credit scores, and medical testing compliance, it can be determined which of the two patients are more likely to require a hospital visit or a trip to an emergency room. The invention also breaks a group of COPD patients into multiple risk categories. One category includes patients that manage their condition very well and therefore have a lower potential for cost avoidance. Assigning them to care management and having a care manager call them will not reduce the cost of care, or significantly improve the outcome. Another category of patients with a higher probability of cost avoidance, however, is the category to which the time and attention of a care manager should be directed. Aggressively managing this category of patients leads to improved outcomes and reduced costs. By utilizing the inventive method and system, the highest potential for cost avoidance can be identified by publishing this information to end users, care managers, care management systems, analytics platforms, stratification systems, and to be recorded in electronic health records (EHR) of providers of such services, e.g., hospitals and emergency rooms.
Referring to
The inventive system 10 receives all of the data from the disparate data sources 12, 14, 16, 18 through an integration service 20. The integration service 20 brokers different protocols of data that are being received from the different disparate data sources 12, 14, 16, 18 so that the data may be transmitted through the inventive system 10 in a uniform fashion. The databases from which data is being received may be file based, IP based and the like and the integration services 20 collects the data regardless of the protocol from which it is being received. Once the data is integrated, it is transformed by a data transformer 22, it is normalized by a data normalizer 24 and it is mapped via a data mapper 26. It should be appreciated by those skilled in the art that any single processor could incorporate all of the steps of the integration services transformation, normalization and mapping into a single unit.
Discreet data is gathered from the disparate data sources 12, 14, 16, 18 include but are not limited to ambulatory systems, inpatient systems, health insurance exchanges, payers, care management systems, hospital systems, claims data, prescription data from pharmacies, pharmacy aggregators and pharmacy benefit managers, labs, patient biometric monitoring devices, credit score agencies, genomic databases and sources and search engines. The ability of the system 10 to support real-time, near real-time exchange of discreet and detailed data is a significant factor in providing accurate and timely population analytics and ATI scores. By way of example, the ATI score may include a factor for a “missed appointment,” whereby an ATI score of a patient is adjusted automatically upon learning that the patient missed an appointment.
The integrated services 20 provides the transport infrastructure and supports current and future standards based interfaces, such as HL7, CCD, CCR, XML, claims, and where applicable the IHE profiles used to integrate such as xdr, xds.b, etc. The integration services 20 also supports custom interfaces, capable of reaching directly into source systems to extract data.
The data that has been transformed, normalized and mapped is indexed by a master patient indexer (MPI) 28. The data is linked by the MPI 28, cleaned and mapped to a healthcare data model in an enterprise data warehouse (EDW) 30. The data that has been received from the disparate data sources, 12, 14, 16, 18 have been integrated, transformed, normalized, mapped and indexed to a particular patient or patient population before it is stored in the EDW 30. This facilitates the execution of analytics on the data set as a whole and provides a more complete and comprehensive view of patients and populations, as well as providers and payers.
Once the indexed data is stored in the EDW 30 it is transformed by a binary data transformer 32 into binary data. The binary data is then partitioned by a binary data partitioner 34.
The EDW 30 also stores historical cost data gathered from the disparate data sources 12, 14, 16, 18, such as payer claims and CMS. By statistically referencing, cross-referencing and analyzing the historical cost information for patients and populations against combinations of the discreet information gathered and organized in the EDW 30, the system 10 is able to identify the specific costs for each data element or factor, and each data element combination. Based on this information, the system 10 will create a patient ATI factor (discussed in greater detail subsequently) for each element. Again, by way of example, a data element would be representative of a condition like COPD or the ability to drive an automobile. Tables will store the actual costs for the patients and populations with the same combinations.
Once the binary data is partitioned, it is sent to a patient factor score calculator 36 and an illness correlation score calculator 38. The output of these two calculators 36, 38 create the ATI score 40. The calculators 36, 38 calculate the waiting, or specific value, for a specific risk factor, which is an ATI factor. Individual ATI factors are added together to create a persons ATI score. ATI scores for individual patients are added together to calculate and create a populations total ATI score. Data and specific factors such as claims, conditions, ICD 9, CPT 4, search engine results, credit scores, social status, diet, exercise, behavioural factors, medical information, active medications, medication compliance, allergies, social history, smoking history, missed scheduled office visits, socialization factors, ability to drive, alcohol consumption, family history, information from health risk assessments as well as other data elements that are gathered and organized in the EDW 30 are assigned an ATI factor. Again, when these ATI factors are added together, the patient and/or a population creates an ATI score. A user of the system 10 may calculate the expected impact upon projected spending and the ATI score of patients and populations by adding or deleting specific ATI factors. For example, if a patient has an ATI factor for blood sugar and is calculated at 0.5, a sample patients total ATI score is 4.5. The same patient responds to an aggressive campaign to reduce the blood sugar level, the result may be a reduced ATI score from 4.5 to 4.0.
By evaluating the spending histories associated with each individual in combination of risk elements for patients and populations with the same factors, the system 10 is able to assign an ATI score associated with the ATI factor for each risk component of that patient. By way of example, a component would include “does not have transportation” and “body mass index” and each could be assigned an ATI factor of 0.5. These ATI factors would be combined to create the patients total ATI score, which would be 1.0 in this case.
Referring to
The illness correlation score aims to categorize rules and weights specific to an illness. With the knowledge of what combinations of factors were seen in the highest cost patients, the system 10 can detect patterns and additionally create alerts to notify clients if new high risk combinations enter the database. The illness correlation score is calculated using a recursive Chi-Squared ranking algorithm. Initially, the binary clinical data is filtered specific to illness/affliction. The binary data is then transformed into 2×2 contingency tables 56, with a corresponding phi coefficient and Chi-Squared statistic. These Chi-Squared statistics are then ranked and combined amongst themselves. The two tier contingency tables with greater values are statistically more significant and when analyzed, are used to generate correlation rules for each illness. Subject matter experts then manually reject or accept the automated rule generation to arrive at a final set of correlations associated with the high cost patients for a specific illness.
Referring to
Referring to
Referring to
Referring to
The invention has been described in an illustrative manner. It is to be understood that the terminology, which has been used, is intended to be in the nature of words of description rather than of limitation.
Many modifications and variations of the invention are possible in light of the above teachings. Therefore, within the scope of the appended claims, the invention may be practiced other than as specifically described.
Number | Date | Country | |
---|---|---|---|
61993444 | May 2014 | US |